NCT01907204View on ClinicalTrials.gov

Evaluation of Inhaled Treatment in Sinusitis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

January 31, 2014

Conditions
Sinusitis
Interventions
DRUG

methylprednisolone

Oral 32mg/8d-16mg/4d-8mg/4d

DRUG

Budesonide

Budesonide by metered dose inhaler

DRUG

Budesonide

Budesonide by nebulization

All Listed Sponsors
lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

NCT01907204 - Evaluation of Inhaled Treatment in Sinusitis | Biotech Hunter | Biotech Hunter